Research ArticleOriginal Research

Primary Care Physicians' Struggle with Current Adult Pneumococcal Vaccine Recommendations

Laura P. Hurley, Mandy A. Allison, Tamara Pilishvili, Sean T. O'Leary, Lori A. Crane, Michaela Brtnikova, Brenda L. Beaty, Megan C. Lindley, Carolyn B. Bridges and Allison Kempe
The Journal of the American Board of Family Medicine January 2018, 31 (1) 94-104; DOI: https://doi.org/10.3122/jabfm.2018.01.170216

References

  1. 1.↵
    1. Huang SS,
    2. Johnson KM,
    3. Ray GT,
    4. et al
    . Healthcare utilization and cost of pneumococcal disease in the United States. Vaccine 2011;29:3398–412.
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    Centers for Disease Control and Prevention. Active Bacterial Core Surveillance (ABCs) Report Emerging Infections Program Network. Streptococcus pneumoniae. Available from: https://www.cdc.gov/abcs/reports-findings/survreports/spneu15.pdf. Accessed November 17, 2017.
  3. 3.↵
    Centers for Disease Control (CDC). Adult immunization. Recommendations of the Immunization Practices Advisory Committee. (ACIP). MMWR Morb Mortal Wkly Rep 1984;33(Suppl 1):1S–68S.
    OpenUrlPubMed
  4. 4.↵
    Centers for Disease Control (CDC). Pneumococcal polysaccharide vaccine. MMWR Morb Mortal Wkly Rep 1989;38:64–8, 73–6.
    OpenUrlPubMed
  5. 5.↵
    Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1997;46(RR-8):1–24.
    OpenUrlPubMed
  6. 6.↵
    Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices. Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23). MMWR Morb Mortal Wkly Rep 2010;59:1102–6.
    OpenUrlPubMed
  7. 7.↵
    1. Moberley S,
    2. Holden J,
    3. Tatham DP,
    4. Andrews RM
    . Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev 2013(1):CD000422.
  8. 8.↵
    Centers for Disease Control and Prevention (CDC). Licensure of 13-valent pneumococcal conjugate vaccine for adults aged 50 years and older. MMWR Morb Mortal Wkly Rep 2012;61:394–5.
    OpenUrlPubMed
  9. 9.↵
    Centers for Disease Control and Prevention (CDC). Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2012;61:816–9.
    OpenUrlPubMed
  10. 10.↵
    1. Bonten MJ,
    2. Huijts SM,
    3. Bolkenbaas M,
    4. et al
    . Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. N Engl J Med 2015;372:1114–25.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Tomczyk S,
    2. Bennett NM,
    3. Stoecker C,
    4. et al
    . Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2014;63:822–5.
    OpenUrlPubMed
  12. 12.↵
    1. Kobayashi M,
    2. Bennett NM,
    3. Gierke R,
    4. et al
    . Intervals between PCV13 and PPSV23 vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2015;64:944–7.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Pilishvili T,
    2. Bennett NM
    . Pneumococcal disease prevention among adults: strategies for the use of pneumococcal vaccines. Vaccine 2015;33(Suppl 4):D60–5.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Williams WW,
    2. Lu PJ,
    3. O'Halloran A,
    4. et al
    . Surveillance of vaccination coverage among adult populations - United States, 2015. MMWR Surveill Summ 2017;66:1–28.
    OpenUrlCrossRef
  15. 15.↵
    1. Nichol KL,
    2. Lofgren RP,
    3. Gapinski J
    . Influenza vaccination. Knowledge, attitudes, and behavior among high-risk outpatients. Arch Intern Med 1992;152:106–10.
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    1. Nichol KL,
    2. MacDonald R,
    3. Hauge M
    . Factors associated with influenza and pneumococcal vaccination behavior among high-risk adults. J Gen Intern Med 1996;11:673–7.
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    1. Armstrong K,
    2. Berlin M,
    3. Schwartz JS,
    4. Propert K,
    5. Ubel PA
    . Barriers to influenza immunization in a low-income urban population. Am J Prev Med 2001;20:21–5.
    OpenUrlPubMedWeb of Science
  18. 18.↵
    1. Winston CA,
    2. Wortley PM,
    3. Lees KA
    . Factors associated with vaccination of medicare beneficiaries in five U.S. communities: results from the racial and ethnic adult disparities in immunization initiative survey, 2003. J Am Geriatr Soc 2006;54:303–10.
    OpenUrlCrossRefPubMedWeb of Science
  19. 19.↵
    University of Colorado. Vaccine policy collaborative initiative. Available from: http://www.ucdenver.edu/academics/colleges/medicalschool/programs/ACCORDS/childrensoutcomesreserach/VaccinePolicyCollaborativeInitiative/Pages/default.aspx. Accessed November 17, 2017.
  20. 20.↵
    1. Crane LA,
    2. Daley MF,
    3. Barrow J,
    4. et al
    . Sentinel physician networks as a technique for rapid immunization policy surveys. Eval Health Prof 2008;31:43–64.
    OpenUrlCrossRefPubMedWeb of Science
  21. 21.↵
    1. Dillman DA,
    2. Smyth J,
    3. Christian LM
    . Internet, mail and mixed-mode surveys: the tailored design method, vol. 3, 3rd ed. New York: John Wiley & Sons; 2009.
  22. 22.↵
    1. Atkeson LR,
    2. Adams AN,
    3. Bryant LA,
    4. Zilberman L,
    5. Saunder KL
    . Considering mixed mode surveys for questions in political behavior: using the internet and mail to get quality data at reasonable costs. Polit Behav 2011;33:161–78.
    OpenUrl
  23. 23.↵
    1. McMahon SR,
    2. Iwamoto M,
    3. Massoudi MS,
    4. et al
    . Comparison of e-mail, fax, and postal surveys of pediatricians. Pediatrics 2003;111(4 Pt 1):e299–303.
    OpenUrlAbstract/FREE Full Text
  24. 24.↵
    1. Hurley LP,
    2. Harpaz R,
    3. Daley MF,
    4. et al
    . National survey of primary care physicians regarding herpes zoster and the herpes zoster vaccine. J InfectDis 2008;197(Suppl 2):S216–23.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Hurley LP,
    2. Bridges CB,
    3. Harpaz R,
    4. et al
    . U.S. physicians' perspective of adult vaccine delivery. Ann Intern Med 2014;160:161.
    OpenUrlCrossRefPubMed
  26. 26.↵
    1. Hurley LP,
    2. Lindley MC,
    3. Allison MA,
    4. et al
    . Primary care physicians' perspective on financial issues and adult immunization in the era of the Affordable Care Act. Vaccine 2017; 35:647–654.
    OpenUrl
  27. 27.↵
    Centers for Medicare and Medicaid Services. Medicare Enrollment Data by State and Age as of July 1, 2012. 2012; Available from: https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/MedicareEnrpts/Downloads/Sageall12.pdf. Accessed February 24, 2016.
  28. 28.↵
    Centers for Disease Control and Prevention. Pneumococcal vaccines (PCV13 and PPSV23). Updated May 2016. Available from: https://www.cdc.gov/vaccines/hcp/adults/downloads/fs-pneumo-hcp.pdf. Accessed February 1, 2017.
  29. 29.↵
    Modifications to Medicare Part B coverage of pneumococcal vaccinations, vol. 2017. Washington (DC): US Department of Health and Human Services; 2013.
  30. 30.↵
    1. Henry J
    . Kaiser Family Foundation. 2017 Employer Benefits Survey. September 19, 2017. Available from: https://www.kff.org/report-section/ehbs-2017-section-13-grandfathered-health-plans/. Accessed 11–17-17.
  31. 31.↵
    1. Stewart AM,
    2. Lindley MC,
    3. Chang KH,
    4. Cox MA
    . Vaccination benefits and cost-sharing policy for non-institutionalized adult Medicaid enrollees in the United States. Vaccine 2014;32:618–23.
    OpenUrlCrossRefPubMed
  32. 32.↵
    Centers for Disease Control and Prevention. Vaccines for Children Program (VFC). CDC vaccine price list. Last reviewed and updated September 1, 2017. https://www.cdc.gov/vaccines/programs/vfc/awardees/vaccine-management/price-list/index.html. Accessed November 17, 2017.
  33. 33.↵
    1. Kempe A,
    2. Hurley LP,
    3. Stokley S,
    4. et al
    . Pneumococcal vaccination in general internal medicine practice: current practice and future possibilities. J Gen Intern Med 2008;23:2010–3.
    OpenUrlCrossRefPubMed
  34. 34.↵
    American Pharmacists Association. Pharmacist administered vaccines: types of vaccines authorized to administer. Updated January 31, 2015. Available from: http://www.pharmacist.com/sites/default/files/files/Pharmacist_IZ_Authority_1_31_15.pdf. Accessed November 17, 2017.
  35. 35.↵
    Immunization information systems progress–United States, 2006. MMWR Morb Mortal Wkly Rep 2008;57:289–91.
    OpenUrlPubMed
  36. 36.↵
    Progress in immunization information systems—United States, 2009. MMWR Morb Mortal Wkly Rep 2011;60:10–2.
    OpenUrlPubMed
  37. 37.↵
    National Vaccine Advisory Committee. Recommendations from the National Vaccine Advisory committee: standards for adult immunization practice. Public Health Rep 2014;129:115–23.
    OpenUrlCrossRefPubMed
  38. 38.↵
    1. Kempe A,
    2. Hurley LP,
    3. Cardemil CV,
    4. et al
    . Use of immunization information systems in primary care. Am J Prev Med 2017;52:173–82.
    OpenUrl
  39. 39.↵
    Centers for Disease Control and Prevention. Pneumococcal vaccine timing for adults. November 30, 2015. Available from: https://www.cdc.gov/vaccines/vpd/pneumo/downloads/pneumo-vaccine-timing.pdf. Accessed February 1, 2017.
  40. 40.↵
    CDSi: Clarity, Consistency, and Computability. Centers for Disease Control and Prevention 2016. Available from: http://www.cdc.gov/vaccines/programs/iis/cdsi.html. Accessed August 14, 2017.
  41. 41.↵
    1. Raz DJ,
    2. Wu GX,
    3. Consunji M,
    4. et al
    . Perceptions and utilization of lung cancer screening among primary care physicians. J Thorac Oncol 2016;11:1856–62.
    OpenUrl
  42. 42.↵
    1. Taylor JR,
    2. Thompson PJ,
    3. Genzen JR,
    4. Hickner J,
    5. Marques MB
    . Opportunities to enhance laboratory professionals' role on the diagnostic team. Lab Med 2017;48:97–103.
    OpenUrlCrossRefPubMed
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Keywords